Indofarma Tbk Stock Price To Earnings To Growth
| INAF Stock | IDR 126.00 0.00 0.00% |
Indofarma Tbk fundamentals help investors to digest information that contributes to Indofarma Tbk's financial success or failures. It also enables traders to predict the movement of Indofarma Stock. The fundamental analysis module provides a way to measure Indofarma Tbk's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Indofarma Tbk stock.
Indofarma |
Indofarma Tbk Company Price To Earnings To Growth Analysis
Indofarma Tbk's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Indofarma Tbk has a Price To Earnings To Growth of 0.0 times. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Indonesia stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Indofarma Fundamentals
| Return On Equity | -0.59 | |||
| Return On Asset | -0.0451 | |||
| Profit Margin | (0.1) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 3.17 T | |||
| Shares Outstanding | 3.1 B | |||
| Shares Owned By Insiders | 88.00 % | |||
| Price To Book | 8.91 X | |||
| Price To Sales | 1.25 X | |||
| Revenue | 2.9 T | |||
| Gross Profit | 442.87 B | |||
| EBITDA | 70.22 B | |||
| Net Income | (37.58 B) | |||
| Total Debt | 397.52 B | |||
| Book Value Per Share | 104.92 X | |||
| Cash Flow From Operations | 92.9 B | |||
| Earnings Per Share | (29.18) X | |||
| Number Of Employees | 1.18 K | |||
| Beta | -0.22 | |||
| Market Capitalization | 2.59 T | |||
| Total Asset | 2.01 T | |||
| Z Score | 4.6 | |||
| Net Asset | 2.01 T |
About Indofarma Tbk Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Indofarma Tbk's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Indofarma Tbk using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Indofarma Tbk based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Indofarma Stock
Indofarma Tbk financial ratios help investors to determine whether Indofarma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Indofarma with respect to the benefits of owning Indofarma Tbk security.